Pangaea Oncology, S.A. (PANG.MC)

EUR 1.68

(0.0%)

Total Debt Summary of Pangaea Oncology, S.A.

Pangaea Oncology, S.A.'s latest annual total debt in 2023 was 5.72 Million EUR , up 64.04% from previous year.
Pangaea Oncology, S.A.'s latest quarterly total debt in 2023 FY was 5.72 Million EUR , up 64.04% from previous quarter.
Pangaea Oncology, S.A. reported annual total debt of 3.49 Million EUR in 2022, down -34.79% from previous year.
Pangaea Oncology, S.A. reported annual total debt of 5.35 Million EUR in 2021, down -20.6% from previous year.
Pangaea Oncology, S.A. reported quarterly total debt of 2.33 Million EUR for 2023 Q1, down -33.04% from previous quarter.
Pangaea Oncology, S.A. reported quarterly total debt of 3.39 Million EUR for 2023 Q2, up 45.08% from previous quarter.

Annual Total Debt Chart of Pangaea Oncology, S.A. (2023 - 2013)

Historical Annual Total Debt of Pangaea Oncology, S.A. (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	5.72 Million EUR	64.04%
2022	3.49 Million EUR	-34.79%
2021	5.35 Million EUR	-20.6%
2020	6.74 Million EUR	81.09%
2019	3.72 Million EUR	-21.69%
2018	4.75 Million EUR	-61.14%
2017	12.23 Million EUR	243.92%
2016	3.55 Million EUR	11.46%
2015	3.19 Million EUR	28.16%
2014	2.49 Million EUR	348.48%
2013	555.5 Thousand EUR	0.0%

Year	Total Debt	Total Debt Growth
2023 FY	5.72 Million EUR	64.04%
2023 Q1	2.33 Million EUR	-33.04%
2023 Q2	3.39 Million EUR	45.08%
2023 Q4	5.72 Million EUR	69.32%
2023 Q3	3.38 Million EUR	-0.27%
2022 Q4	3.49 Million EUR	0.0%
2022 FY	3.49 Million EUR	-34.79%
2022 Q2	4.64 Million EUR	0.0%
2021 FY	5.35 Million EUR	-20.6%
2021 Q4	5.35 Million EUR	0.0%
2021 Q2	6.31 Million EUR	0.0%
2020 Q2	4.84 Million EUR	0.0%
2020 FY	6.74 Million EUR	81.09%
2020 Q4	6.74 Million EUR	0.0%
2019 Q4	3.72 Million EUR	0.0%
2019 FY	3.72 Million EUR	-21.69%
2019 Q2	4.36 Million EUR	0.0%
2018 Q4	4.75 Million EUR	0.0%
2018 Q2	10.72 Million EUR	0.0%
2018 FY	4.75 Million EUR	-61.14%
2017 FY	12.23 Million EUR	243.92%
2017 Q4	12.23 Million EUR	0.0%
2017 Q2	4.18 Million EUR	0.0%
2016 Q2	3.34 Million EUR	0.0%
2016 FY	3.55 Million EUR	11.46%
2016 Q4	3.55 Million EUR	0.0%
2015 Q4	3.19 Million EUR	0.0%
2015 FY	3.19 Million EUR	28.16%
2014 FY	2.49 Million EUR	348.48%
2013 FY	555.5 Thousand EUR	0.0%

Peer Total Debt Comparison of Pangaea Oncology, S.A.

Name	Total Debt	Total Debt Difference
Clínica Baviera, S.A.	47.27 Million EUR	87.879%